echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > Baolight intends to spend 11.7 million yuan to set up a joint venture to develop

    Baolight intends to spend 11.7 million yuan to set up a joint venture to develop

    • Last Update: 2021-05-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On April 19, Bolaite issued an announcement that, based on strategic planning and business development needs, in order to expand the blood purification market, the company plans to jointly fund and establish a holding subsidiary Sichuan Bolaite Zhili Medical Technology Co.


    Among them: the company invested RMB 11.


    Bolaite stated that the establishment of a joint venture with Zhili Medical will further improve the national layout and give full play to the advantages of existing channels and sales networks, scale advantages and synergy.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.